Notably, SVF administration resulted in significant downregulation of fibrotic markers, including fibronectin (FN), collagen I (Col I), and α-smooth muscle actin (αSMA), at both the protein and transcript levels (Figures 2C,D), indicating suppression of obstruction-induced renal fibrosis. The gene discussed is ACTA1; the disease is renal fibrosis.